First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy
Go back to First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.50 | 52 Week High | $63.73 | |||
| Open | $17.50 | 52 Week Low | $8.00 | |||
| Day High | $17.50 | P/E | N/A | |||
| Day Low | $17.50 | EPS | $-5.69 | |||
| Volume | 187 | |||||
